Wilkie A O, Zeitlin H C, Lindenbaum R H, Buckle V J, Fischel-Ghodsian N, Chui D H, Gardner-Medwin D, MacGillivray M H, Weatherall D J, Higgs D R
Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, England.
Am J Hum Genet. 1990 Jun;46(6):1127-40.
We have identified five unrelated patients, all of north European origin, who have hemoglobin H (Hb H) disease and profound mental handicap. Surprisingly, detailed molecular analysis of the alpha globin complex is normal in these subjects. Clinically, they present with a rather uniform constellation of abnormalities, notably severe mental handicap, microcephaly, relative hypertelorism, unusual facies and genital anomalies. Hematologically, their Hb H disease has subtly but distinctly milder properties than the recognized Mendelian forms of the disease. These common features suggest that these five "nondeletion" patients have a similar underlying mutation, quite distinct from the 16p13.3 deletion associated with alpha thalassemia and mild to moderate mental retardation described in the accompanying paper. We speculate that the locus of this underlying mutation is not closely linked to the alpha globin complex and may encode a trans-acting factor involved in the normal regulation of alpha globin expression.
我们已鉴定出五名无血缘关系的患者,他们均来自北欧,患有血红蛋白H(Hb H)病且有严重智力障碍。令人惊讶的是,这些受试者α珠蛋白复合体的详细分子分析结果正常。临床上,他们表现出一组相当一致的异常症状,尤其是严重智力障碍、小头畸形、相对眼距过宽、面容异常和生殖器畸形。血液学方面,他们的Hb H病与已确认的孟德尔式疾病相比,症状虽细微但明显较轻。这些共同特征表明,这五名“非缺失型”患者具有相似的潜在突变,与随附论文中描述的与α地中海贫血及轻度至中度智力障碍相关的16p13.3缺失截然不同。我们推测这种潜在突变的基因座与α珠蛋白复合体没有紧密联系,可能编码一种参与α珠蛋白表达正常调控的反式作用因子。